MINNEAPOLIS, March 12, 2024 /PRNewswire/ -- Bio-Techne
Corporation (NASDAQ: TECH) today announced that Will Geist, President, Protein Sciences Segment,
will present at the KeyBanc Life Sciences & MedTech Investor
Forum on Tuesday, March 19, 2024, at
9:45 a.m. EDT. A live webcast of the
presentation can be accessed via the IR Calendar page of
Bio-Techne's Investor Relations website at
https://investors.bio-techne.com/ir-calendar.
About Bio-Techne (NASDAQ: TECH)
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences
company providing innovative tools and bioactive reagents for the
research and clinical diagnostic communities. Bio-Techne products
assist scientific investigations into biological processes and the
nature and progress of specific diseases. They aid in drug
discovery efforts and provide the means for accurate clinical tests
and diagnoses. With thousands of products in its portfolio,
Bio-Techne generated over $1.1
billion in net sales in fiscal 2023 and has approximately
3,100 employees worldwide. For more information on Bio-Techne and
its brands, please visit http://www.bio-techne.com or follow
the Company on social media at Facebook, LinkedIn, Twitter or
YouTube.
Contact:
|
David Clair, Vice
President, Investor Relations & Corporate
Development
|
|
|
david.clair@bio-techne.com
|
|
|
612-656-4416
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-keybanc-life-sciences--medtech-investor-forum-302086247.html
SOURCE Bio-Techne Corporation